Agile Therapeutics Inc (AGRX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Alfred F. Altomari
Employees:
30
101 POOR FARM ROAD, PRINCETON, NJ 08540-1715
609-683-1880

Agile Therapeutics, Inc. researches, develops, and commercializes prescription contraceptive products. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of line extensions and other products.

Data derived from most recent annual or quarterly report
Market Cap 6.462 Million Shares Outstanding2.692 Million Avg 30-day Volume 46.944 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue0.32 Debt to Equity-0.1289 EBITDA-16.432 Million
Price to Book Value0.0 Operating Margin-229.3815 Enterprise Value3.998 Million
Current Ratio0.761 EPS Growth0.981 Quick Ratio0.473
1 Yr BETA -0.4998 52-week High/Low 11.5 / 0.18 Profit Margin-116.8271
Operating Cash Flow Growth46.3419 Free Cash Flow to Firm (FCFF) TTM -9.827 Million Free Cash Flow to Equity (FCFE) TTM
Altman Z-Score-49.9209
Earnings Report2023-11-07
View SEC Filings from AGRX instead.

View recent insider trading info

Agile Therapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding AGRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AGRX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 3: filed on 2023-08-25 by COIANTE SCOTT M
  • 4: filed on 2023-06-30 by WELSH AMY
  • 4: filed on 2023-06-30 by KORNER PAUL
  • 4: filed on 2023-06-30 by ALTOMARI ALFRED
  • 4: filed on 2023-06-30 by CONWAY ROBERT G
  • 4: filed on 2023-06-30 by GILMORE GEOFFREY
  • 4: filed on 2023-06-09 by TORRENTE JOSEPHINE
  • 4: filed on 2023-06-09 by FISCHER SETH H. Z.
  • 4: filed on 2023-06-09 by HUBBARD JOHN W
  • 4: filed on 2023-06-09 by CARSON SANDRA

    • Events (8k)

  • 8-K: filed on 2023-10-02:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2023-09-28:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K/A: filed on 2023-08-22:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-30:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-06-27:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K/A: filed on 2023-06-14:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-08:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-06-05:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2023-05-25:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    COIANTE SCOTT M CHIEF FINANCIAL OFFICER

    • Officer
    		 80 2023-08-16 1

    ALTOMARI ALFRED CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 47,749 2023-06-28 2

    GILMORE GEOFFREY CHIEF ADMINISTRATIVE OFFICER

    • Officer
    		 20,256 2023-06-28 2

    KORNER PAUL CHIEF MEDICAL OFFICER

    • Officer
    		 13,500 2023-06-28 2

    CONWAY ROBERT G CHIEF SUPPLY CHAIN OFFICER

    • Officer
    		 13,529 2023-06-28 2

    WELSH AMY CHIEF COMMERCIAL OFFICER

    • Officer
    		 13,500 2023-06-28 3

    BARBARI SHARON

    • Director
    		 974 2023-06-08 1

    FISCHER SETH H. Z.

    • Director
    		 976 2023-06-08 1

    HUBBARD JOHN W

    • Director
    		 976 2023-06-08 1

    CARSON SANDRA

    • Director
    		 974 2023-06-08 1

    TORRENTE JOSEPHINE

    • Director
    		 988 2023-06-08 1

    BUTCH JASON PRINCIPAL ACCOUNTING OFFICER

    • Officer
    		 6,000 2022-11-09 1

    TURSI JAMES PATRICK

    • Director
    		 2,873 2022-06-09 0

    SHETTY AJIT

    • Director
    		 3,048 2022-06-09 0

    REILLY DENNIS CHIEF FINANCIAL OFFICER

    • Officer
    		 275,000 2022-01-19 0

    PERCEPTIVE ADVISORS LLC

    PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

    EDELMAN JOSEPH

    • 10% Owner
    		 21,654,485 2021-10-13 0

    MCKEE WILLIAM

    • Director
    		 0 2019-06-06 0

    LELE ABHIJEET J

    • Director
    		 0 2019-06-06 0

    GARNER ELIZABETH SR. VP & CHIEF MEDICAL OFFICER

    • Officer
    		 0 2019-01-29 0

    CARE CAPITAL III LLC

    CARE CAPITAL INVESTMENTS III L.P.

    CARE CAPITAL OFFSHORE INVESTMENTS III LP

    • 10% Owner
    		 No longer subject to file 2018-04-18 0

    SELMAN RENEE CHIEF COMMERCIAL OFFICER

    • Officer
    		 71,628 2018-01-24 0

    HONG KAREN

    • Director
    		 0 2016-06-08 0

    AISLING CAPITAL III LP

    AISLING CAPITAL PARTNERS III LLC

    AISLING CAPITAL PARTNERS III LP

    ELMS STEVE

    PURCELL DENNIS J

    SCHIFF ANDREW N

    • 10% Owner
    		 No longer subject to file 2016-06-02 0

    MACFARLANE KATIE CHIEF COMMERCIAL OFFICER

    • Officer
    		 0 2016-02-08 0

    MOORIN JAY

    SCHREIBER ALAIN

    PROQUEST INVESTMENTS III, L.P.

    PROQUEST ASSOCIATES III LLC

    PROQUEST INVESTMENTS IV, L.P.

    PROQUEST ASSOCIATES IV LLC

    • 10% Owner
    		 5,062,363 2016-01-27 0

    SCHIFF ANDREW N

    • Director
    		 0 2015-06-10 0

    INVESTOR AB

    • 10% Owner
    		 3,509,949 2014-05-29 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    AGILE THERAPEUTICS INC AGRX 2023-10-02 22:15:03 UTC -56.6847 62.0047 150000
    AGILE THERAPEUTICS INC AGRX 2023-10-02 21:45:03 UTC -56.6847 62.0047 150000
    AGILE THERAPEUTICS INC AGRX 2023-10-02 21:15:04 UTC -56.6847 62.0047 150000
    AGILE THERAPEUTICS INC AGRX 2023-10-02 20:45:04 UTC -56.6847 62.0047 150000
    AGILE THERAPEUTICS INC AGRX 2023-10-02 20:15:03 UTC -56.6847 62.0047 150000
    AGILE THERAPEUTICS INC AGRX 2023-10-02 19:45:03 UTC -56.6847 62.0047 150000
    AGILE THERAPEUTICS INC AGRX 2023-10-02 19:15:03 UTC -56.6847 62.0047 150000
    AGILE THERAPEUTICS INC AGRX 2023-10-02 18:45:04 UTC -56.6847 62.0047 150000
    AGILE THERAPEUTICS INC AGRX 2023-10-02 18:15:04 UTC -56.6847 62.0047 150000
    AGILE THERAPEUTICS INC AGRX 2023-10-02 17:45:04 UTC -56.6847 62.0047 150000
    AGILE THERAPEUTICS INC AGRX 2023-10-02 17:15:03 UTC -56.6847 62.0047 150000
    AGILE THERAPEUTICS INC AGRX 2023-10-02 16:45:04 UTC -56.6847 62.0047 150000
    AGILE THERAPEUTICS INC AGRX 2023-10-02 16:15:04 UTC -56.6847 62.0047 150000
    AGILE THERAPEUTICS INC AGRX 2023-10-02 15:45:04 UTC -56.6847 62.0047 150000
    AGILE THERAPEUTICS INC AGRX 2023-10-02 15:15:04 UTC -56.6847 62.0047 150000
    AGILE THERAPEUTICS INC AGRX 2023-10-02 14:45:03 UTC -56.6847 62.0047 150000
    AGILE THERAPEUTICS INC AGRX 2023-10-02 14:15:03 UTC -56.6847 62.0047 150000
    AGILE THERAPEUTICS INC AGRX 2023-10-02 13:45:04 UTC -49.7412 55.0612 150000
    AGILE THERAPEUTICS INC AGRX 2023-10-02 13:15:05 UTC -49.7412 55.0612 60000
    AGILE THERAPEUTICS INC AGRX 2023-10-02 12:45:05 UTC -49.7412 55.0612 45000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments